Texas Tech University Health Sciences Center
ttuhsc.eduMatched: Texas Tech University Health Sciences Center, El Paso · Texas Tech University Health Sciences Center
Live pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
142
Active
22
Phase 3
5
Total enrollment
8,784
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Cefadroxil 500 mg | — | — | — | — | — | 1 | |
| Clindamycin | — | — | — | — | — | 1 | |
| Bactrim DS | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | — | 1 | |
| standard general anesthesia | — | — | — | — | — | 1 | |
| linaclotide or placebo | — | — | — | — | — | 1 | |
| sulforaphane | — | — | — | — | — | 2 | |
| DeltaGold® Tocotrienol 70% | — | — | — | — | — | 2 | |
| Low curcumin group | — | — | — | — | — | 1 | |
| High curcumin group | — | — | — | — | — | 1 | |
| Cryoablation combined with PD1 Inhibitor | — | — | — | — | — | 1 | |
| Pecan snack | — | — | — | — | — | 1 | |
| Pretzel snack | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Zynrelef | — | — | — | — | — | 1 | |
| Exparel | — | — | — | — | — | 1 |
Next readouts
- 2024-12-30
- 2026-10
- 2026-12-31
- 2027-01
- 2027-05
- 2027-11-01
- 2027-12-30
- 2027-12-31
- 2028-09-30
- 2028-11-01
Top conditions
- Obesity10
- Breast Cancer7
- Low Back Pain5
- Burns4
- Tuberculosis3
- Respiratory Failure3
- Vitamin D Deficiency2
- Multiple Sclerosis2
Frequently asked questions about Texas Tech University Health Sciences Center
- How many clinical trials does Texas Tech University Health Sciences Center have on ClinicalTrials.gov?
- Texas Tech University Health Sciences Center is listed as the lead sponsor on 142 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Texas Tech University Health Sciences Center's trials are in Phase 3?
- 5 of Texas Tech University Health Sciences Center's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does Texas Tech University Health Sciences Center focus on?
- Texas Tech University Health Sciences Center's most-studied conditions on ClinicalTrials.gov are Obesity, Breast Cancer, Low Back Pain, Burns, Tuberculosis.
- When are Texas Tech University Health Sciences Center's next clinical trial readouts?
- Texas Tech University Health Sciences Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Tocotrienols for Obesity of Postmenopausal Women”, expected around 2024-12-30.